Via BBC News, a long article: WHO faces questions over swine flu policy. Excerpt:
The WHO has struggled to offer clear answers on the question of its definition of a pandemic, partly because of its policy of keeping the identity and the deliberations of its pandemic emergency advisory committee secret. The only known member of the committee is its chairman, Australian flu specialist John MacKenzie.
WHO spokesman Gregory Hartl said names of those on the sitting committee had not been made public because of the potential “for bringing undue pressure on them when they are making decisions which have societal and economic impacts”.
The lack of transparency in its decision making process, together with the WHO’s advice to countries to begin widespread vaccination against swine flu, has led some observers to suspect undue influence from the pharmaceutical industry.
Looking at the balance sheets of the pharmaceutical companies it is clear that many did make a healthy profit out of swine flu. Vaccine producer Novartis, for example, posted an 8% jump in profit in 2009. The company’s annual report cites swine flu vaccine sales as a major reason for the increase - though such a profit is, of course, not proof of any undue influence by the firm.
These medical products have cost national health budgets billions. France, for example, spent over 600m euros ($739m, £515m) on 94 million doses of vaccine, most of which have not been used.
“Who benefited from what happened?” asked British Labour Member of Parliament Paul Flynn. “Really the only people to benefit were the pharmaceutical companies. I’m not saying I’m drawing any firm conclusions, but there are legitimate questions here.”
News Editor





